Clinical characteristics | Total (449) | % | |
---|---|---|---|
Age at diagnosis(y) | 60 (26–90) | ||
Sex | male | 289 | 64.4 |
female | 160 | 35.6 | |
Grade | G1 | 12 | 2.7 |
G2 | 189 | 42.4 | |
G3 | 173 | 38.8 | |
G4 | 70 | 15.7 | |
Gx | 2 | 0.4 | |
NA | 3 | ||
Cancer status | With tumor | 126 | 29.5 |
Tumor free | 296 | 69.3 | |
Discrepancy | 5 | 1.2 | |
NA | 22 | . | |
Stage | I | 219 | 49.1 |
II | 45 | 10.1 | |
III | 106 | 23.8 | |
IV | 76 | 17 | |
NA | 3 | ||
Tumor size | T1 | 225 | 50.1 |
T2 | 56 | 12.5 | |
T3 | 159 | 35.4 | |
T4 | 9 | 2 | |
Lymph nodes | Negative | 199 | 93.4 |
Positive | 14 | 6.6 | |
NA | 236 | ||
Distant metastasis | Negative | 366 | 83.2 |
Positive | 74 | 16.8 | |
NA | 9 | ||
Hemoglobin result | Elevated | 4 | 1 |
Low | 227 | 59 | |
Normal | 154 | 40 | |
NA | 64 | ||
History of neoadjuvant treatment | No | 435 | 96.9 |
Yes | 14 | 3.1 | |
Serum calcium result | Elevated | 8 | 2.6 |
Low | 176 | 56.2 | |
Normal | 129 | 41.2 | |
NA | 136 |